Complications of injections in conservative treatment of degenerative spine disease: a prospective unicentric study.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
22 Nov 2022
Historique:
received: 16 08 2022
accepted: 09 11 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 26 11 2022
Statut: epublish

Résumé

Spinal injection has been an accepted part of conservative therapy for degenerative diseases. The drugs used can cause side effects and severe complications. The aim of this study was to determine the occurrence of general side effects (GSE) and complications when performing consecutive different types of spinal injections and to evaluate pain reduction. Prospective data evaluation of patients with degenerative spine disease at hospital admission, discharge, and six and 12 weeks after discharge. All patients received a specific injection protocol depending on their symptoms and radiological findings. The injections performed were dorsal sacroiliac joint injections, perineural injections, epidural interlaminar and epidural periradicular injections, and facet joint injections. Potential complications were categorized and recorded as GSE and complications. In addition, the Numerical Analog Scale (NAS) for pain, the Oswestry Disability Index (ODI) were evaluated. Forty-eight patients were enrolled. There were 282 spinal injections performed. A total of 131 common treatment-related events were recorded. Depending on the type of injection, transient pain at the injection site (32.4-73.5%), radiating pain (9.4-34.7%), and nerve root irritation (2-18.4%) were the most common. One complication with postpuncture syndrome occurred with epidural-interlaminar injection. No persistent neurologic deficits occurred. The highest rate of GSE was observed with periradicular injections (relative frequency (RF) = 0.8), followed by epidural-interlaminar injections (RF = 0.65), least frequently with FJ injections (RF = 0.32). From the time of admission to discharge, NAS scores were significantly decreased and ODI score significantly improved at discharge (p < 0.001), but relapse occurred at the 12-week follow-up. Various consecutive spinal injections for conservative treatment of degenerative spine diseases are safe and lead to a decrease in pain and improvement in quality of life. GSE are common, but not persistent. Although complications are rare, they can have serious consequences for the patient.

Sections du résumé

BACKGROUND BACKGROUND
Spinal injection has been an accepted part of conservative therapy for degenerative diseases. The drugs used can cause side effects and severe complications. The aim of this study was to determine the occurrence of general side effects (GSE) and complications when performing consecutive different types of spinal injections and to evaluate pain reduction.
METHODS METHODS
Prospective data evaluation of patients with degenerative spine disease at hospital admission, discharge, and six and 12 weeks after discharge. All patients received a specific injection protocol depending on their symptoms and radiological findings. The injections performed were dorsal sacroiliac joint injections, perineural injections, epidural interlaminar and epidural periradicular injections, and facet joint injections. Potential complications were categorized and recorded as GSE and complications. In addition, the Numerical Analog Scale (NAS) for pain, the Oswestry Disability Index (ODI) were evaluated.
RESULTS RESULTS
Forty-eight patients were enrolled. There were 282 spinal injections performed. A total of 131 common treatment-related events were recorded. Depending on the type of injection, transient pain at the injection site (32.4-73.5%), radiating pain (9.4-34.7%), and nerve root irritation (2-18.4%) were the most common. One complication with postpuncture syndrome occurred with epidural-interlaminar injection. No persistent neurologic deficits occurred. The highest rate of GSE was observed with periradicular injections (relative frequency (RF) = 0.8), followed by epidural-interlaminar injections (RF = 0.65), least frequently with FJ injections (RF = 0.32). From the time of admission to discharge, NAS scores were significantly decreased and ODI score significantly improved at discharge (p < 0.001), but relapse occurred at the 12-week follow-up.
CONCLUSIONS CONCLUSIONS
Various consecutive spinal injections for conservative treatment of degenerative spine diseases are safe and lead to a decrease in pain and improvement in quality of life. GSE are common, but not persistent. Although complications are rare, they can have serious consequences for the patient.

Identifiants

pubmed: 36419001
doi: 10.1186/s12891-022-05970-x
pii: 10.1186/s12891-022-05970-x
pmc: PMC9682701
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1002

Informations de copyright

© 2022. The Author(s).

Références

Arch Orthop Trauma Surg. 2022 Apr 14;:
pubmed: 35420357
Eur J Orthop Surg Traumatol. 2015 Jul;25 Suppl 1:S177-82
pubmed: 25708619
Pain Physician. 2022 Mar;25(2):145-160
pubmed: 35322968
Clin Nucl Med. 2000 Jan;25(1):71-3
pubmed: 10634544
Can J Anaesth. 1993 Jan;40(1):83-4
pubmed: 8425252
Pain Physician. 2002 Apr;5(2):182-99
pubmed: 16902669
Pain Physician. 2004 Oct;7(4):427-9
pubmed: 16858483
Pain Physician. 2015 Jul-Aug;18(4):325-31
pubmed: 26218935
Pain Med. 2008 Mar;9(2):227-34
pubmed: 18298706
Pain Physician. 2012 Nov-Dec;15(6):515-23
pubmed: 23159970
Br J Anaesth. 2003 Nov;91(5):718-29
pubmed: 14570796
J Spinal Disord Tech. 2003 Jun;16(3):285-7
pubmed: 12792344
Spine (Phila Pa 1976). 2012 Dec 1;37(25):E1567-71
pubmed: 23196966
Pain Med. 2016 Dec;17(12):2185-2202
pubmed: 28025354
Pain Physician. 2016 Jul;19(6):389-96
pubmed: 27454269
Drugs. 2001;61(3):333-42
pubmed: 11293644
Pain Physician. 2007 Jan;10(1):229-53
pubmed: 17256032
Pain Physician. 2014 Nov-Dec;17(6):E691-702
pubmed: 25415784
Curr Opin Anaesthesiol. 2008 Oct;21(5):645-50
pubmed: 18784493
Curr Rev Musculoskelet Med. 2008 Dec;1(3-4):212-22
pubmed: 19468908
Pain Med. 2014 Mar;15(3):386-402
pubmed: 24308846
Reg Anesth. 1995 May-Jun;20(3):249-51
pubmed: 7547665
Curr Pain Headache Rep. 2020 Sep 29;24(11):67
pubmed: 32990823
Eur Spine J. 2017 Feb;26(2):336-344
pubmed: 26873103
Pain Physician. 2007 Sep;10(5):697-705
pubmed: 17876368
Pain Physician. 2012 Mar-Apr;15(2):131-40
pubmed: 22430650
Semin Immunopathol. 2020 Dec;42(6):669-680
pubmed: 33219395
J Int Med Res. 2021 May;49(5):3000605211012367
pubmed: 33942634
Pain Physician. 2005 Jan;8(1):101-14
pubmed: 16850048
Ann Emerg Med. 2021 Sep;78(3):443-450
pubmed: 33966935
Pain Physician. 2014 Jul-Aug;17(4):E489-501
pubmed: 25054399
Pain Physician. 2014 Jul-Aug;17(4):E451-74
pubmed: 25054397

Auteurs

Anna Voelker (A)

Department for Orthopedics, Trauma and Plastic Surgery, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany. anna.voelker@medizin.uni-leipzig.de.

Markus Pirlich (M)

Clinic of Otolaryngology, Head and Neck Surgery, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany.

Christoph-Eckhard Heyde (CE)

Department for Orthopedics, Trauma and Plastic Surgery, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH